Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: An experimental study in the rabbit

A Systematic Review and Meta-analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with α-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

(2012) Mauro Gacci et al.   EUROPEAN UROLOGY

Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells

(2012) Linda Vignozzi et al.   JOURNAL OF ENDOCRINOLOGY

Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome

(2012) Annamaria Morelli et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Reduced Vascular Nitric Oxide–cGMP Signaling Contributes to Adipose Tissue Inflammation During High-Fat Feeding

(2011) Priya Handa et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The Correlation Between Metabolic Syndrome and Prostatic Diseases

(2011) Cosimo De Nunzio et al.   EUROPEAN UROLOGY

Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit

(2011) Linda Vignozzi et al.   JOURNAL OF ENDOCRINOLOGY

Phosphodiesterase Type 5 Expression in Human and Rat Lower Urinary Tract Tissues and the Effect of Tadalafil on Prostate Gland Oxygenation in Spontaneously Hypertensive Rats

(2011) Annamaria Morelli et al.   Journal of Sexual Medicine

Spermatogenic and sperm quality differences in an experimental model of metabolic syndrome and hypogonadal hypogonadism

(2011) Con Mallidis et al.   REPRODUCTION

Phosphodiesterase type 5 (PDE5) in the adipocyte: a novel player in fat metabolism?

(2011) Andrea Armani et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Differentiation of Effector CD4 T Cell Populations

(2010) Jinfang Zhu et al.   Annual Review of Immunology

Farnesoid X receptor activation improves erectile dysfunction in models of metabolic syndrome and diabetes

(2010) Annamaria Morelli et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Activity of phosphodiesterase type 5 inhibitors in patients with lower urinary tract symptoms due to benign prostatic hyperplasia

(2010) Chen Zhao et al.   BJU INTERNATIONAL

Lifestyle factors, benign prostatic hyperplasia, and lower urinary tract symptoms

(2010) JK Parsons   CURRENT OPINION IN UROLOGY

Attenuated Proliferation andTrans-Differentiation of Prostatic Stromal Cells Indicate Suitability of Phosphodiesterase Type 5 Inhibitors for Prevention and Treatment of Benign Prostatic Hyperplasia

(2010) Christoph Zenzmaier et al.   ENDOCRINOLOGY

Vardenafil Decreases Bladder Afferent Nerve Activity in Unanesthetized, Decerebrate, Spinal Cord–Injured Rats

(2010) Delphine Behr-Roussel et al.   EUROPEAN UROLOGY

Farnesoid X Receptor Activation Improves Erectile Function in Animal Models of Metabolic Syndrome and Diabetes

(2010) Linda Vignozzi et al.   Journal of Sexual Medicine

Testosterone and Metabolic Syndrome: A Meta‐Analysis Study

(2010) Giovanni Corona et al.   Journal of Sexual Medicine

The Effects of Aging on the Molecular and Cellular Composition of the Prostate Microenvironment

(2010) Daniella Bianchi-Frias et al.   PLoS One

Lower urinary tract symptoms, obesity and the metabolic syndrome

(2009) Samdeep Moul et al.   CURRENT OPINION IN UROLOGY

Effects of Phosphodiesterase Inhibitors on the Inflammatory Response of Endothelial Cells Stimulated by Myeloperoxidase-Modified Low-Density Lipoprotein or Tumor Necrosis Factor Alpha

(2009) Thierry Roumeguère et al.   EUROPEAN UROLOGY

Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases

(2009) G. Corona et al.   INTERNATIONAL JOURNAL OF ANDROLOGY

Chronic inflammation in the pathogenesis of benign prostatic hyperplasia

(2009) B. Fibbi et al.   INTERNATIONAL JOURNAL OF ANDROLOGY

Human Benign Prostatic Hyperplasia Stromal Cells As Inducers and Targets of Chronic Immuno-Mediated Inflammation

(2009) G. Penna et al.   JOURNAL OF IMMUNOLOGY

Testosterone Partially Ameliorates Metabolic Profile and Erectile Responsiveness to PDE5 Inhibitors in an Animal Model of Male Metabolic Syndrome

(2009) Sandra Filippi et al.   Journal of Sexual Medicine

Vardenafil Modulates Bladder Contractility Through cGMP-mediated Inhibition of RhoA/Rho Kinase Signaling Pathway in Spontaneously Hypertensive Rats

(2009) Annamaria Morelli et al.   Journal of Sexual Medicine

Acute Vardenafil Administration Improves Bladder Oxygenation in Spontaneously Hypertensive Rats

(2009) Annamaria Morelli et al.   Journal of Sexual Medicine

Characterization of Phosphodiesterase Type 5 Expression and Functional Activity in the Human Male Lower Urinary Tract

(2009) Benedetta Fibbi et al.   Journal of Sexual Medicine

Lower urinary tract symptoms, benign prostatic hyperplasia, and obesity

(2009) Anne K. Mongiu et al.   Current Urology Reports